Contact
    Start Publications Encapsulation and release of doxycycline from ...
    ←  Publication Finder
    Attension

    Encapsulation and release of doxycycline from electrospray-generated PLGA microspheres: Effect of polymer end groups

    Year: 2019

    Journal: Int. J. Pharm., Volume 564, JUN 10, page 1–9

    Authors: Wang, Jiamian; Helder, Leonie; Shao, Jinlong; Jansen, John A.; Yang, Mingshi; Yang, Fang

    Organizations: Chinese Scholarship CouncilChina Scholarship Council [201506170058]

    Keywords: PLGA microspheres; Polymer end group; Electrospraying; Encapsulation efficiency; Drug release profile

    The aim of this study was to investigate the influence of end group of poly(lactic-co-glycolic acid) (PLGA) on the drug loading and release behavior of electrospray-generated PLGA microspheres. To this end, doxycycline hyclate (DOX) was selected as a model drug, and PLGA (molecular weight 17 and 44 kDa) with either an acid or ester end group were electrosprayed with DOX. The processing parameters were optimized to obtain microspheres comparable in size. Drug loading efficiency and release profile were determined by the high-performance liquid chromatography-ultraviolet detection (HPLC-UV) method. PLGA polymers or drug-loaded microspheres were characterized before and after exposure to phosphate buffer saline at 37 degrees C regarding the wettability of polymers, pH changes of the buffer, molecular weight of PLGA and morphology of the microspheres. The acid end group of PLGA microspheres brought about lower encapsulation efficiency and faster DOX release rate in our study, indicating that different hydrophilicity of polymer and degradation speed were the main reasons causing a difference in encapsulation efficiency and release profile. In addition, DOX released from the PLGA microspheres was active by showing antibacterial effects against Potphyromonas gingivalis as measured using a zone of inhibition test, and varying the end groups showed no impact on the antibacterial efficacy. This study demonstrated that the end group of PLGA can be used as a new tool to regulate drug encapsulation efficiency and release rate to meet different clinical drug delivery requirements.
    View publication